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Feeding on high-calorie (HC) diets induces serious
metabolic imbalances, including obesity. Under-
standing the mechanisms against excessive body
weight gain is critical for developing effective anti-
obesity strategies. Here we show that lack of nico-
tinamide adenine dinucleotide (NAD+)-dependent
deacetylase SIRT1 in pro-opiomelanocortin (POMC)
neurons causes hypersensitivity to diet-induced
obesity due to reduced energy expenditure. The
ability of leptin to properly engage the phosphoinosi-
tide 3-kinase (PI3K) signaling in POMC neurons and
elicit remodeling of perigonadal white adipose tissue
(WAT) is severely compromised in mutant mice.
Also, electrophysiological and histomorphomolecu-
lar analyses indicate a selective reduction in sympa-
thetic nerve activity and brown-fat-like characteris-
tics in perigonadal WAT of mutant mice, suggesting
a physiologically important role for POMC neurons
in controlling this visceral fat depot. In summary,
our results provide direct genetic evidence that
SIRT1 in POMC neurons is required for normal auto-
nomic adaptations against diet-induced obesity.
INTRODUCTION
Chronic feeding on diets rich in calories induces several serious
metabolic defects, including obesity (Wisse et al., 2007). Homeo-
static defense mechanisms against diet-induced obesity com-
prise behavioral and autonomic adaptations (e.g., reduced
food intake and increased energy expenditure) (Dhillon et al.,
2006; Lowell and Spiegelman, 2000; Tong et al., 2008). The
molecular mechanisms and the neuronal populations that
coordinate these defense mechanisms are only partially known.
These include actions of hormones (e.g., leptin, insulin) on
specialized central nervous system (CNS) neurons, as for exam-
ple POMC neurons (Balthasar et al., 2004; Hill et al., 2008).78 Cell Metabolism 12, 78–87, July 7, 2010 ª2010 Elsevier Inc.POMC neurons reside in hypothalamic arcuate nucleus (ARH)
and hindbrain nucleus of the solitary tract (NTS) (Bronstein
et al., 1992; Elias et al., 1999). These neurons belong to the
central melanocortin system, a family of diverse cells that com-
prise agouti-related peptide (AgRP)-, melanocortin-3-receptor
(MC3R)-, and melanocortin-4-receptor (MC4R)-expressing neu-
rons. POMC neurons secrete, along with other neuropeptides,
a-melanocyte stimulating hormone (a-MSH), which suppresses
food intake and increases energy expenditure by activating
MC3Rs and MC4Rs (Coll et al., 2004; Fan et al., 1997). AgRP
neurons secrete, along with other neuropeptides, AgRP that is
the endogenous antagonist at the same melanocortin receptors
(Cone et al., 1996; Ollmann et al., 1997). Because genetic
defects impairing the function of brain melanocortin system
result in obesity (in rodents and humans) (Butler et al., 2000;
Butler et al., 2001; Farooqi et al., 2000, 2006), whereas increased
a-MSH expression restrains diet-induced obesity (Lee et al.,
2007), POMC neurons have served as prototypes for investi-
gating the mechanisms underpinning normal energy homeo-
stasis (Cone, 2005; O’Rahilly et al., 2003).
In addition to brain/peripheral feedback loop pathways, cell-
intrinsic, metabolic-sensing mechanisms in CNS neurons are
also critical for body energy balance. For example, AMP-
activated protein kinase and mammalian target of rapamycin in
hypothalamic centers are both required for proper leptin sensing
and hence body weight homeostasis (Claret et al., 2007; Cota
et al., 2006; Minokoshi et al., 2004). SIRT1 is also a metabolic-
sensor protein, as it uses oxidized nicotinamide adenine dinucle-
otide (NAD+) to deacetylate proteins (Imai et al., 2000). In periph-
eral tissues, SIRT1 regulates various metabolic processes. For
example, deletion or reduction in the expression of SIRT1 in liver
results in hypoglycemia and hypersensitivity to diet-induced
hepatic steatosis (Erion et al., 2009; Li et al., 2007; Purushotham
et al., 2009; Rodgers and Puigserver, 2007). Conversely,
increased SIRT1 gene dosage in hepatocytes leads to deacety-
lation and thus activation of peroxisome proliferators activated
receptor (PPAR)-g coactivator 1a (PGC-1a) and forkhead box
O1 (FoxO1) and hence enhanced expression of key genes of
the gluconeogenic program (Banks et al., 2008). In skeletal
muscle, SIRT1 activates PGC-1a but inhibits protein tyrosine
phosphatase (PTP) 1B (a negative regulator of the insulin
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Figure 1. Deletion of SIRT1 Is Restricted to
POMC Neurons
Representative photomicrographs of brain slices
from Pomc-Cre; Z/EG (control) or Pomc-Cre;
Sirt1loxP/loxP; Z/EG mice stained for SIRT1 and
GFP (the Cre-conditional expression of GFP is
restricted only to POMC neurons in these mice
[Balthasar et al., 2004]). Dark brown staining and
green fluorescence represent SIRT1 and GFP
immunoreactivity, respectively. Higher magnifica-
tion of the boxed region is in the top left corner of
the photomicrograph. Arrows indicate POMC
neurons. Note the colocalization between SIRT1
and POMC in Pomc-Cre; Z/EG control brain. This
colocalization is absent in almost all of POMC
neurons in Pomc-Cre; Sirt1loxP/loxP; Z/EG brain.
Dash lines indicate ARH boundaries. Abbrevia-
tions: third ventricle (3V), hypothalamic arcuate
nucleus (ARH), immunohistochemistry (IHC).
Scale bar, 50 mm.
Cell Metabolism
Metabolic Actions of SIRT1 in POMC Neuronsreceptor signaling cascade) (Gerhart-Hines et al., 2007; Sun
et al., 2007) and hence enhances mitochondrial activity, fatty
acid b oxidation, and insulin sensitivity. In pancreatic b cells,
increased SIRT1 gene expression improves glucose-stimulated
insulin secretion and body glucose tolerance (Moynihan et al.,
2005). In adipocytes, SIRT1 reduces lipogenesis and adipogen-
esis through mechanisms involving inhibition of PPAR-g (Picard
et al., 2004).
In contrast to peripheral tissues, little is known about the rele-
vance of SIRT1 in the brain on metabolic homeostasis. SIRT1 is
expressed in the hypothalamus, where its expression increases
following fasting (Ramadori et al., 2008). Acute inhibition of
hypothalamic SIRT1 dampens fasting-induced hyperphagia in
rats (Cakir et al., 2009). Thus, because SIRT1 is expressed in
POMC neurons (Ramadori et al., 2008), we reasoned that this
metabolic-sensor protein in these metabolic-sensor neurons
may play a critical role for coordinated body energy homeo-
stasis. To directly test this hypothesis, we generated and charac-
terized mice lacking SIRT1 only in POMC neurons.
RESULTS
Somatic Deletion of SIRT1 in POMC Neurons
Cre-mediated deletion of a loxP-flanked Sirt1 allele (Sirt1loxP)
results in a Sirt1 null allele (Cheng et al., 2003). Thus, to ablate
SIRT1 selectively in POMC neurons, the Sirt1loxP allele was
bred to the Pomc-Cre transgene that we and others have
demonstrated expresses functional Cre-recombinase only in
POMC cells (Balthasar et al., 2004; Belgardt et al., 2008; Plum
et al., 2006, 2009). Genotyping PCR analyses of several tissues
demonstrated the presence of the Cre-deleted, Sirt1 null allele
in sites known to express POMC in Pomc-Cre mice homozygous
for the Sirt1loxP allele (henceforward referred to as Pomc-Cre;
Sirt1loxP/loxP mice) (see Figure S1 available online). The Cre-
deleted, Sirt1 null allele in the pituitary gland is expectedbecause POMC is also expressed in corticotrophs and melano-
trophs (Belgardt et al., 2008), but without metabolic conse-
quences as Pomc-Cre; Sirt1loxP/loxP mice have normal circadian
fluctuations of serum corticosterone levels (Table S1). To directly
investigate whether mutant mice lack SIRT1 in all POMC
neurons, we performed double immunohistochemistry (IHC) for
SIRT1 and GFP in Pomc-Cre; Sirt1loxP/loxP; Z/EG and Pomc-
Cre; Z/EG (control) brains. The Z/EG allele was introduced to
allow expression of GFP selectively in POMC neurons, as previ-
ously described (Balthasar et al., 2004). Virtually all ARH POMC
neurons expressed SIRT1 in control brains (176 out of 180
POMC cells [98%] were positive for SIRT1 immunoreactivity;
Figure 1, upper panel). Conversely, only 7% of ARH POMC
neurons expressed SIRT1 in Pomc-Cre; Sirt1loxP/loxP; Z/EG
brains (14 out of 197 POMC neurons were positive for SIRT1
immunoreactivity; Figure 1, lower panel). Notably, SIRT1 expres-
sion was undisturbed in ARH non-POMC (GFP-negative) cells of
mutant mice, a result that further supports the POMC-neuron
specificity of SIRT1 deletion (Figure 1).
Because SIRT1 has been suggested to exert neuroprotective
actions (Kim et al., 2007; Qin et al., 2006), we assessed if SIRT1
deficiency affects survival of POMC neurons. The anatomical
distribution of b-endorphin (a product of POMC neurons) in the
CNS of Pomc-Cre; Sirt1loxP/loxP mice was normal (Figure 2A
and data not shown). The number of ARH and NTS POMC
neurons as well as their projections to hypothalamic and extrahy-
pothalamic sites did not differ between mutants and controls
(Figures 2B and 2C). Hypothalamic and hindbrain Pomc mRNA
contents and the levels of POMC-derived neuropeptides adre-
nocorticotropic hormone (ACTH), corticotropin-like intermediate
lobe peptide (CLIP), and a-MSH in hypothalamus were also
unchanged (Figures 3A–3C and data not shown). Altogether,
these data demonstrate that Pomc-Cre; Sirt1loxP/loxP mice lack
SIRT1 specifically in POMC neurons and that absence of
SIRT1 does not alter POMC neurons survival.Cell Metabolism 12, 78–87, July 7, 2010 ª2010 Elsevier Inc. 79
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Figure 2. SIRT1 Is Dispensable for POMC Neurons Survival
(A) Representative photomicrographs of rostral to caudal (top to bottom) brain sections from either Sirt1loxP/loxP (control) or Pomc-Cre, Sirt1loxP/loxP mice stained
for b-endorphin (a product of POMC). Dark brown staining represents b-endorphin immunoreactivity. Scale bar, 200 mm.
(B) POMC neurons were counted in several sections that contained similar regions of the hypothalamus or hindbrain in both genotypes. No difference in the
estimated number of POMC neurons per section was noted between genotypes in 4-week-old males (4-wks M), 4-week-old females (4-wks F), 20-week-old
males (20-wks M), and 12-week-old females fed on the HC diet for 4 weeks (12-wks F HC).
(C) Representative photomicrographs of brain sections from either Sirt1loxP/loxP (control) or Pomc-Cre, Sirt1loxP/loxP mice stained for b-endorphin. Dark brown
staining represents b-endorphin immunoreactive fibers. Both genotypes display similar POMC neurons fibers density in dorsomedial hypothalamic nucleus
(DMH), paraventricular hypothalamic nucleus (PVH), and paraventricular thalamic nucleus (PVT). Scale bar, 100 mm. Other abbreviations: third ventricle (3V),
immunohistochemistry (IHC). n = 2–3 in each group. Error bars represent SEM. Statistical analyses were done using two-tailed unpaired Student’s t test.
Cell Metabolism
Metabolic Actions of SIRT1 in POMC NeuronsBody Energy Imbalance in Mice Lacking SIRT1 Only
in POMC Neurons
Pomc-Cre; Sirt1loxP/loxP mice were born at the expected Mende-
lian ratio and thrived into adulthood similarly to controls, allowing
us to investigate the physiological outcomes of POMC-neuron-
specific SIRT1 deletion. Pomc-Cre; Sirt1loxP/loxP males and
females fed ad libitum on a standard chow (SC) diet had body
weights undistinguishable from their Sirt1loxP/loxP littermates
(Figures 4A and 4B). Body fat and lean mass were assessed by
magnetic resonance imaging (MRI) and found to be within the
physiological range in SC-fed mutant mice (data not shown).
Body length was also normal (Table S1), thus indicating that
lack of SIRT1 in POMC neurons does not alter adiposity in
mice fed on a regular diet. However, when animals were chal-
lenged with HC diet, body energy imbalance emerged in mutant
mice. Pomc-Cre; Sirt1loxP/loxP males had a slight tendency to
increased body weight (Figures 4A), whereas mutant females
displayed a striking hypersensitivity to diet-induced obesity, as
their body weights were significantly elevated compared to
controls fed on the same HC diet (Figure 4B). MRI analysis indi-
cated that the increased body weight was solely due to
increased fat mass (Figure 4C). Microcomputed tomography80 Cell Metabolism 12, 78–87, July 7, 2010 ª2010 Elsevier Inc.imaging suggested that visceral fat was enlarged (Figure 4D).
In fact, mutant mice had almost double the mass of the major
visceral fat depot (i.e., perigonadal fat) compared to controls,
a defect brought about by the HC diet, as it was not seen in
SC-fed mutants (Figure 4E). Circulating levels of the adipocyte-
secreted hormone leptin also tended to be elevated (Figure 4F),
an effect that we suggest is part of compensatory mechanisms
aimed at restraining excessive body weight gain caused by
SIRT1 deletion in POMC neurons. Energy imbalance was not
secondary to hypercorticosteronemia (Table S1) or altered
expression of key hypothalamic neuropeptides regulating
energy balance (Figure 3A and Figure S2). Although central mel-
anocortins are critical for normal glucose and lipid homeostasis
(Nogueiras et al., 2007; Parton et al., 2007), glycemia, insuline-
mia, insulin sensitivity, glucose tolerance, triglyceridemia, and
serum nonesterified fatty acids were unchanged in mutant
mice (Table S1 and data not shown). Altogether, these results
demonstrate that SIRT1 in POMC neurons is required for normal
defenses against diet-induced obesity.
Energy homeostasis is kept in equilibrium when energy intake
equals energy expenditure over time (Spiegelman and Flier,
2001). Autonomic and behavioral adaptations to prevent
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Figure 3. Normal Hypothalamic Pomc
mRNA and POMC-Derived Peptides Levels
in Mice Lacking SIRT1 in POMC Neurons
(A) Hypothalamic Pomc mRNA level in 4-week-old
and 28-week-old Sirt1loxP/loxP and Pomc-Cre;
Sirt1loxP/loxP females fed on a high calorie (HC)
diet for 20 weeks (n = 9–11). Pomc mRNA levels
were normalized to b-actin mRNA contents.
(B) Schematic diagram depicting POMC process-
ing in hypothalamus.
(C) Hypothalamus was collected from 12-week-
old Sirt1loxP/loxP and Pomc-Cre; Sirt1loxP/loxP
females fed on a HC diet for 4 weeks (n = 9–11).
Acid-extracted peptides were HPLC fractionated
and quantified for ACTH or a-MSH using specific
radioactive immunoassays. Representative HPLC
profile for ACTH-related peptides and values of
ACTH peptide for each group are shown (upper
panel). Representative HPLC profile for a-MSH-
related peptides and values of desacetyl-a-MSH
peptide for each group are shown (lower panel).
Each HPLC profile displays the elution position of
respective synthetic standards. Values are the
mean ± SEM. Statistical analyses were done using
two-tailed unpaired Student’s t test, and no differences were noted between groups. Abbreviations: ACTH (adrenocorticotropic hormone), CLIP (corticotropin-
like intermediate lobe peptide), a-MSH (alpha melanocyte-stimulating hormone), and b-LPH (beta lipotropin hormone).
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Metabolic Actions of SIRT1 in POMC Neuronsexcessive body weight gain in mammals fed on a hypercaloric
diet are (1) increased energy expenditure (a phenomenon
referred to as diet-induced thermogenesis) and (2) reduced
food intake (Dhillon et al., 2006; Lowell and Spiegelman, 2000),
respectively. To investigate the mechanisms underlying hyper-
sensitivity to diet-induced obesity in Pomc-Cre; Sirt1loxP/loxP
mice, we measured acute and chronic metabolic adjustments
to the HC diet. Mutant mice increased energy expenditure and
decreased food intake during the 4 days that immediately fol-
lowed the switch from SC to HC diet, similarly to their controls
(Figures S3A and S3B). However, after 4 weeks on the HC diet,
O2 consumption, CO2, and heat production were reduced inWeeks of age
B
o
d
y
 
W
e
i
g
h
t
 
(
g
)
Sirt1loxP/loxP
Pomc-Cre; Sirt1loxP/loxP
HC
SC
Males
A C E
0
5
10
15
20
25
W
e
i
g
h
t
 
(
g
)
Fat        Lean 
*
Sirt1loxP/loxP
Pomc-Cre; Sirt1loxP/loxP
Sirt1loxP/loxP Pomc-Cre; 
Sirt1loxP/loxP
HC
SC
*
*
*
Weeks of age
B
o
d
y
 
W
e
i
g
h
t
 
(
g
)
Females
Sirt1loxP/loxP
Pomc-Cre; Sirt1loxP/loxP
6 8
1
0
1
2
1
4
1
6
1
8
2
0
2
2
2
4
2
6
2
8
3
0
15
20
25
30
*
*
*
*
6 8
1
0
1
2
1
4
1
6
1
8
2
0
2
2
2
4
2
6
2
8
3
0
15
20
25
30
35
40
45
B                     D FPomc-Cre; Sirt1loxP/loxP mice (Figure 5A). Importantly, at the
time these metabolic parameters were assessed, body weight
and composition as well as leptinemia were still normal in mutant
mice (Figure S3C), thus suggesting that reduced energy expen-
diture is not a consequence of the increased body adiposity but
rather is causing it. Fuel type utilization (carbohydrates versus
lipids) was not affected by SIRT1 deletion in POMC neurons,
as the average respiratory quotient did not differ between geno-
types (Figure 5A). Of note, the reduced metabolic rate was not
the result of hypoactivity, because ambulatory movements
were unaltered in Pomc-Cre; Sirt1loxP/loxP mice (Figure 5B).
Despite established anorectic roles for POMC neurons0
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Figure 4. SIRT1 in POMC Neurons Is
Required for Normal Defenses against
Diet-Induced Obesity in Females
(A) Body weight curves of SC-fed Sirt1loxP/loxP
(n = 17) and Pomc-Cre, Sirt1loxP/loxP (n = 20) males,
HC-fed Sirt1loxP/loxP (n = 15) and Pomc-Cre,
Sirt1loxP/loxP (n = 20) males; and (B) SC-fed
Sirt1loxP/loxP (n = 33) and Pomc-Cre, Sirt1loxP/loxP
(n = 37) females, HC-fed Sirt1loxP/loxP (n = 14) and
Pomc-Cre, Sirt1loxP/loxP (n = 19) females. (C)
Body composition, (D) representative microcom-
puted tomography images, (E) mass of hemiperi-
gonadal fat, and (F) serum leptin levels of
Sirt1loxP/loxP and Pomc-Cre, Sirt1loxP/loxP females
after 20 weeks on the HC diet (n = 10–19). Mass
of hemiperigonadal fat of 28-week-old SC-fed
Sirt1loxP/loxP (n = 12) and Pomc-Cre, Sirt1loxP/loxP
(n = 12) females is shown in (E). In all figures,
HC-fed mice were fed on a SC diet up to 8 weeks
of age and then switched and maintained on a HC
diet. In (D), red and yellow/green colors represent
lean and fat mass, respectively. Arrows indicate
visceral adipose tissue. Error bars represent
SEM. Statistical analyses were done using two-
tailed unpaired Student’s t test. *p < 0.05.
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Figure 5. Normophagia but Reduced
Energy Expenditure Following Chronic Hy-
percaloric Feeding in Females Lacking
SIRT1 in POMC Neurons
(A) O2 consumption, CO2 and heat production,
respiratory quotient (RQ), (B) ambulatory move-
ments, and (C) food intake were measured before
body weight diverged in 12-week-old Sirt1loxP/loxP
and Pomc-Cre, Sirt1loxP/loxP females fed on a HC
diet for 4 weeks (n = 12 in each group). Data
were collected using the Columbus Instruments
Comprehensive Lab Animal Monitoring System
(CLAMS). Time 0 represents the beginning of the
dark cycle in a 12 hr dark/light cycle environment.
Black and white boxes represent dark and light
cycles, respectively. Error bars represent SEM.
Statistical analyses were done using two-tailed
unpaired Student’s t test. *p < 0.05.
Cell Metabolism
Metabolic Actions of SIRT1 in POMC Neurons(Cone, 2005), food intake before and during the dynamic phase
of excessive body weight gain was normal in mutant mice (Fig-
ure 5C, Figure S3D). Collectively, our data demonstrate that
SIRT1 in POMC neurons is required for normal energy expendi-
ture and body weight homeostasis after chronic hypercaloric
feeding.
Impaired BAT-like Remodeling of Perigonadal WAT
in Pomc-Cre; Sirt1loxP/loxP Mice
To identify the defective tissue(s) underlying the impaired energy
expenditure, we focused on brown adipose tissue (BAT)
because of its established roles in mediating diet-induced ther-
mogenesis (Lowell and Spiegelman, 2000). Through stimulation
of the sympathetic nervous system activity (SNA), HC diet
enhances dissipation of chemical energy in the form of heat in
brown adipocytes. This physiological adjustment is achieved,
at least in part, through activation of PGC1a-dependent path-
ways that lead to mitochondriogenesis and increased expres-
sion of BAT-selective genes (e.g., uncoupling protein 1 [UCP1])
(Seale et al., 2009). To gather insights into BAT functions, we
assessed Ucp1 and Pgc1a mRNA contents and the weight of
interscapular BAT but found these parameters to be normal in
Pomc-Cre; Sirt1loxP/loxP HC-fed mice (Figure 6A and data not
shown). Next, we focused on characterizing brown adipocytes’
function in other tissues in which these cells are known to exert
important antiobesity actions as well (Kopecky et al., 1995; Plum
et al., 2007; Seale et al., 2009). We first assessed UCP1 expres-
sion in several visceral (perigonadal, perirenal, and mesenteric)
and subcutaneous (inguinal and mammary) WAT depots and in
skeletal muscle. Ucp1 mRNA and protein contents were signifi-
cantly and selectively reduced in the perigonadal fat depot of
Pomc-Cre; Sirt1loxP/loxP females (Figures 6B and 6C and data
not shown). Similarly, mRNA contents of the BAT-specific gene
Cidea were also selectively reduced in this fat depot (Figure 6B).
It is noteworthy that impaired expression of BAT-specific genes
as well as that of key genes for mitochondrial biogenesis and
function preceded changes in body adiposity (Figure S4A), sug-82 Cell Metabolism 12, 78–87, July 7, 2010 ª2010 Elsevier Inc.gesting that these defects are not consequences of the energy
imbalance but rather contribute to its development. To further
investigate these visceral BAT abnormalities, we performed
histomorphological analyses. Several multilocular/UCP1-
expressing brown adipocytes were present in perigonadal
WAT of Sirt1loxP/loxP HC-fed females (Figure 6D). In contrast,
significantly fewer brown adipocytes were found embedded in
this visceral fat depot of Pomc-Cre; Sirt1loxP/loxP HC-fed mice
(Figure 6D). Altogether, these data indicate that POMC neurons
selectively regulate BAT-like remodeling of perigonadal WAT.
Reduced SNA in Perigonadal WAT of Pomc-Cre;
Sirt1loxP/loxP Mice
HC-induced changes in hormonal levels lead to increased
energy expenditure in part via enhanced SNA in diverse periph-
eral tissues (Plum et al., 2007; Rahmouni et al., 2004). To explore
whether the hypersensitivity to diet-induced obesity was due to
altered sympathetic nervous system function, we directly as-
sessed the electrophysiological properties of nerves subserving
different fat depots (of note, only sympathetic nerves are found
within fat tissues [Bartness and Song, 2007]). To rule out the
possibility that eventual difference in SNA may have been
secondary to dissimilarities in body energy statuses, these
measurements were performed before body weights and
adiposity differed between mutants and controls. As shown in
Figure 6E and Figure S4B, these assays indicated a selective
impairment in SNA in perigonadal WAT as nerve activity was
normal in interscapular BAT and inguinal WAT but greatly
reduced in perigonadal fat of mutant mice. In agreement with
the electrophysiological data, the amounts of UCP1 and tyrosine
hydroxylase (TH, an enzyme required for synthesis of catechol-
amines), which are known to positively correlate with SNA in
fat tissues, were also normal in interscapular BAT but reduced
in perigonadal WAT of mutant mice (Figure 6C and Fig-
ure S4C). Collectively, these results pinpoint a selective reduc-
tion in SNA in perigonadal WAT of Pomc-Cre; Sirt1loxP/loxP
HC-fed mice.
A D
Sirt1loxP/loxP
Pomc-Cre; Sirt1loxP/loxP
S
i
r
t
1
l
o
x
P
/
l
o
x
P
P
o
m
c
-
C
r
e
;
 S
i
r
t
1
l
o
x
P
/
l
o
x
P
H&E           UCP1 IHC
100μm
100μm
100μm
R
e
l
a
t
i
v
e
 
m
R
N
A
 
l
e
v
e
l
R
e
la
t
i
v
e
 
m
R
N
A
 
le
v
e
l
IBAT
*
**
Sirt1loxP/loxP
Pomc-Cre; Sirt1loxP/loxP
U
c
p
1
C
id
e
a
0.0
0.5
1.0
1.5
U
c
p
1
C
id
e
a
0.0
0.5
1.0
1.5
2.0
U
c
p
1
C
id
e
a
0
1
2
3
U
c
p
1
C
id
e
a
0.0
0.5
1.0
1.5
U
c
p
1
C
id
e
a
0.0
0.5
1.0
1.5
U
c
p
1
P
g
c
1
α
0.0
0.5
1.0
1.5
Sirt1loxP/loxP
Pomc-Cre; Sirt1loxP/loxP
0
10
20
30
40
50
0.0
0.5
1.0
1.5
2.0
P
e
r
i
g
o
n
a
d
a
l
S
N
A
 
(
v
*
s
e
c
/
m
i
n
)
P
e
r
i
g
o
n
a
d
a
l
S
N
A
 
(
s
p
ik
e
s
/s
e
c
)
***
*
B E
Perigonadal Perirenal Mesenteric               Inguinal                Mammary
C F
*
Placebo                        CL316,243
Before      After               Before      After  
Sirt1loxP/loxP
Pomc-Cre; 
Sirt1loxP/loxP
B
o
d
y
 
W
e
i
g
h
t
 
(
g
)
*
20
25
30
35
†
β-actin
Sirt1loxP/loxP
Pomc-Cre; 
Sirt1loxP/loxP
UCP1
Figure 6. Altered BAT and Sympathetic Nerve Activity in Perigonadal Fat of Females Lacking SIRT1 in POMC Neurons
(A) Ucp1 and Pgc1a mRNA levels in interscapular brown adipose tissue (IBAT) of 28-week-old Sirt1loxP/loxP and Pomc-Cre; Sirt1loxP/loxP females fed on a high
calorie (HC) diet for 20 weeks.
(B) Ucp1 and Cidea mRNA levels in visceral (perigonadal, perirenal, mesenteric) and subcutaneous (inguinal and mammary) white adipose tissue (WAT) of same
mice as in (A) (n = 7–11). Individual mRNA levels were normalized to b-actin mRNA contents.
(C) UCP1 and b-actin (used as loading control) protein levels were assessed in the perigonadal fat of same mice as in (A) (UCP1/b-actin content is reduced in
mutants; p = 0.021; n = 3–4) by western blot.
(D) Representative photomicrographs of paraffin-embedded perigonadal WAT sections stained with hematoxylin and eosin (H&E) or treated for UCP1 immuno-
histochemistry (IHC). Tissues were collected from same mice as in (A). Dark brown staining represents UCP1-expressing brown adipocytes. Higher magnification
of the boxed region is in the top right corner. Scale bar, 100 mm.
(E) Quantification of SNA in perigonadal WAT of 12-week-old Sirt1loxP/loxP and Pomc-Cre; Sirt1loxP/loxP females fed on a HC diet for 4 weeks (n = 8).
(F) Body weights before and after 1 week of treatment with either placebo or the selective b3-adrenergic receptor agonist CL316,243 (n = 15–16). Error bars
represent SEM. Statistical analyses were done using two-tailed unpaired Student’s t test. yp = 0.05, *p < 0.05, **p < 0.01, **p < 0.001.
Cell Metabolism
Metabolic Actions of SIRT1 in POMC NeuronsTo test if reversal of the defect in BAT contents in perigonadal
WAT would rescue body energy imbalance, we treated mice with
the selective b3-adrenergic receptor agonist CL316,243, which is
known to potently stimulate accumulation of BAT in perigonadal
WAT (Seale et al., 2008). As shown in Figure 6F, before
CL316,243 or placebo treatment began, Pomc-Cre; Sirt1loxP/loxP
HC-fed mice were heavier than controls. Remarkably, treatment
with b3-adrenoreceptor agonist completely rescued this body
weight phenotype in a food intake-independent fashion (Figure 6F
and data not shown), thus suggesting an underlying energy expen-
diture component. In agreement with this hypothesis, CL316,243
treatment increased BAT-specific gene expression and the
abundance of multilocular/UCP1-expressing brown adipocytes in
perigonadal WAT to levels that were indistinguishable between
genotypes (Figure S4D). These results suggest that defects
upstream of b3-adrenergic receptor signaling (e.g., reduced SNA)
underlie the impaired perigonadal WAT to BAT remodeling and
body weight imbalance in Pomc-Cre; Sirt1loxP/loxP HC-fed mice.Altered Biological Actions of Leptin in Pomc-Cre;
Sirt1loxP/loxP Mice
Leptinexertspleiotropic actions including the concurrent inhibition
and activation of diverse hypothalamic neurons that leads to
reduced food intake and increased energy expenditure in part
via enhanced SNA and BAT in perigonadal WAT (Hill et al., 2008;
Plum et al., 2007). Thus, to determine whether SIRT1 in POMC
neurons is required for leptin’s biological actions, mutants and
controls were challenged with intracerebroventricular (icv) admin-
istration of leptin. As shown in Figures 7A and 7B, icv leptin treat-
ment decreased body weight in mutants and controls to similar
extents; however, leptin’s acute anorectic effects (i.e.:, from
days 2 to 6 after treatment began) were impaired in mutant mice.
A blunted acute anorectic response to exogenously administered
leptin in animals that are otherwise normophagic (Figures 5C and
7B and Figure S3D) strongly resembles the metabolic outcomes of
impaired PI3K signaling in POMC neurons (Hill et al., 2008). Next,
we assessed the ability of central leptin administration to enhanceCell Metabolism 12, 78–87, July 7, 2010 ª2010 Elsevier Inc. 83
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Figure 7. SIRT1 in POMC Neurons Is
Required for Normal Biological Actions of
Leptin
(A and B) (A) Relative body weights of HC-fed
Sirt1loxP/loxP and Pomc-Cre, Sirt1loxP/loxP mice
during the 10 days of icv delivery of either placebo
or leptin and (B) food intake from the second to the
sixth and from the sixth to the tenth day into the
treatment.
(C) Ucp1 and Cidea mRNA levels in perigonadal
WAT at the end of the treatment (n = 8–10). Indi-
vidual mRNA levels were normalized to b-actin
mRNA contents.
(D) Representative photomicrographs of brain
slices from Pomc-Cre; FoxO1-GFP (control) or
Pomc-Cre; Sirt1loxP/loxP; FoxO1-GFP mice stained
for GFP (the Cre-conditional expression of
FoxO1-GFP is restricted only to POMC neurons
in these mice). Scale bar, 20 mm. Error bars repre-
sent SEM. Statistical analyses were done using
one-way ANOVA (Tukey’s post test). *p < 0.05,
**p < 0.01, **p < 0.001 Sirt1loxP/loxP leptin versus
Sirt1loxP/loxP placebo. #p < 0.05, ##p < 0.01,
Pomc-Cre, Sirt1loxP/loxP leptin versus Pomc-Cre,
Sirt1loxP/loxP placebo.
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Metabolic Actions of SIRT1 in POMC NeuronsBAT in perigonadal WAT, an effect also known to be mediated by
hypothalamic PI3K signaling (Plum et al., 2007). Leptin treatment
almost tripled the amount ofUcp1andCideamRNA inperigonadal
WAT of control mice (P values = 0.05, leptin versus placebo), an
effect that was virtually absent in Pomc-Cre; Sirt1loxP/loxP mice
(Figure 7C). Histomorphological analyses confirmed the impaired
perigonadal WAT to BAT remodeling induced by central leptin
administration in mutants (Figure S5).
As mentioned above, the plasticity of this visceral WAT is
under the control of leptin-induced PI3K signaling in hypotha-
lamic neurons (Plum et al., 2007). Thus, we investigated if lack
of SIRT1 diminishes the ability of leptin to properly engage the
PI3K pathway in POMC neurons. To directly test this hypothesis,
we introduced the Cre-conditional FoxO1-GFP allele (Fukuda
et al., 2008) in either Pomc-Cre or Pomc-Cre; Sirt1loxP/lox mice.
By exploiting the robustness of FoxO1 nuclear exclusion upon
PI3K activation, the nucleocytoplasmic shuttling of FoxO1-GFP
has been successfully used for monitoring PI3K signaling in
hypothalamic neurons (Fukuda et al., 2008). In basal conditions,
FoxO1-GFP was localized in nucleus and cytoplasm of control
POMC neurons, whereas it was significantly more abundantly
localized in the nucleus of POMC neurons lacking SIRT1
(Figure 7D). Also, leptin-induced nuclear exclusion of FoxO1-
GFP was severely blunted in mutant POMC neurons (Figure 7D),
demonstrating that SIRT1 is required for normal leptin-induced
activation of PI3K signaling in these neurons. Altogether, these
in vivo and in vitro data demonstrate that SIRT1 in POMC
neurons is necessary for normal leptin’s physiological (i.e.,
reduced food intake and increased BAT in perigonadal WAT)
and molecular (i.e., activation of PI3K signaling) actions; thus,
lack of SIRT1 in POMC neurons causes leptin resistance.
DISCUSSION
SIRT1 is a protein deacetylase whose targets include histones,
transcription factors, and cofactors (Imai et al., 2000; Michan84 Cell Metabolism 12, 78–87, July 7, 2010 ª2010 Elsevier Inc.and Sinclair, 2007). The long-term effects of CNS SIRT1 on
body weight homeostasis are, however, controversial, as
reduced food intake has been observed following knockdown
of hypothalamic SIRT1 (Cakir et al., 2009) but also in mice with
enhanced SIRT1 activity (Banks et al., 2008). Our findings estab-
lish SIRT1 in the brain, and more specifically in POMC neurons,
as an important molecular component of long-term control of
body weight homeostasis. Indeed, we found that SIRT1 in
POMC neurons is required for normal energy expenditure adap-
tations and hence body weight homeostasis following HC diet
feeding. Interestingly, our results indicate that the outcomes of
SIRT1 deletion in POMC neurons on body weight balance are
more pronounced in females than in males (Figure 4). To better
understand the underlying causes of this effect, we first
assessed if SIRT1 deletion in POMC neurons alters TH and
BAT-like contents in perigonadal WAT in males as it does in
females. Interestingly, TH and UCP1 protein levels in perigonadal
WAT of mutant males were also reduced compared to controls
(Figure S4E), suggesting that SIRT1 in POMC neurons is required
for normal diet-induced remodeling of this visceral fat depot in
both genders. The sexual dimorphic body weight phenotype
may then be due to the fact that the contribution of BAT in peri-
gonadal WAT on body energy balance differs between genders.
This hypothesis seems to be plausible, as males have far fewer
brown-like adipocytes and 10-fold less BAT-specific gene
expression in this tissue compared to age- and diet-matched
females (Figure S4E and data not shown). Thus, we speculate
that the reduced BAT in perigonadal WAT is a defect sufficient
to cause overt body energy imbalance in females, but not in
males.
The normophagia in mutant mice is surprising, considering the
fact that POMC neurons govern both arms of the energy balance
(Cone, 2005). The anorectic effects of POMC neurons are medi-
ated, at least in part, by a-MSH and its actions on downstream
MC4R-expressing neurons in paraventricular hypothalamic
nucleus (Balthasar et al., 2005; Coll et al., 2004; Fan et al.,
Cell Metabolism
Metabolic Actions of SIRT1 in POMC Neurons1997; Plum et al., 2009). But, as shown in Figures 2 and 3,
POMC projections to this brain area as well as hypothalamic
contents of a-MSH, and Pomc mRNA are normal in mutant
mice. Furthermore, phenotypes found in mammals bearing
Pomc or Mc4r null mutations, as for example increased body
length, hyperinsulinemia, glucose intolerance, and abnormal
lipid metabolism (Farooqi et al., 2006; Huszar et al., 1997; No-
gueiras et al., 2007), were not seen in Pomc-Cre; Sirt1loxP/loxP
mice (Table S1 and data not shown), suggesting that SIRT1
deletion in POMC neurons does not lead to overt dysfunctions
of the CNS melanocortin system. Thus, the reduced energy
expenditure without concurrent changes in food intake in mutant
mice pinpoints to a divergence in CNS SIRT1-dependent mech-
anisms of body weight control. Our aforementioned results,
however, may seem to be in conflict with a previous study
reporting reduced food intake and body weight in rats in which
ARH SIRT1 expression was reduced by small interfering RNAs
delivery (Cakir et al., 2009). These discrepancies may be ex-
plained by the following not mutually exclusive possibilities: (1)
because our experiments were done in mice whereas Cakir
and colleagues employed rats, it may be possible that the roles
of hypothalamic SIRT1 on energy balance are different in these
two species; and/or (2) the acute (Cakir et al., 2009) and chronic
(as reported here) losses of SIRT1 in POMC neurons have
opposite effects on body weight; and/or (3) because Cakir and
colleagues undertook an approach that was not POMC-
neuron-specific, it may be possible that the acute anorectic
consequences of diminished ARH SIRT1 they reported were
mediated by non-POMC cells (e.g., AgRP neurons). Future
studies employing animal models bearing AgRP-neuron-
specific SIRT1 loss- or gain-of-function mutations will be
required to directly test this latter hypothesis.
Leptin-induced activation of PI3K signaling in hypothalamic
neurons has been previously reported to selectively enhance
SNA and BAT in perigonadal and pararenal WAT (Plum et al.,
2007). Our study shows a selective and physiological relevant
connection from POMC neurons to perigonadal WAT. Also, we
identified SIRT1 as a critical molecular component of leptin-
sensing mechanisms in CNS neurons. Indeed, our in vitro and
in vivo experiments shown in Figure 7 indicate that lack of
SIRT1 in POMC neurons causes impaired responsiveness to
leptin: at the molecular level, leptin-induced activation of the
PI3K-FoxO1 signaling cascade is impaired in POMC neurons
lacking SIRT1; at the organismal level, the ability of icv leptin
administration to acutely reduce food intake and enhance BAT
in perigonadal WAT is blunted in mutant mice. Although it will
require additional experiments to totally understand the modali-
ties by which SIRT1 regulates the PI3K signaling in central
neurons, one candidate pathway may involve PTP1B-dependent
mechanisms, as SIRT1 suppresses PTP1B that is a negative
regulator of the PI3K signaling cascade (Sun et al., 2007).
Another possibility is that SIRT1 directly deacetylates molecular
components of the leptin-receptor-PI3K-FoxO1 signaling
cascade, as suggested by the fact that FoxO1 itself is deacety-
lated (i.e., activated) by SIRT1. Because it has been previously
postulated that FoxO1 regulates Pomc gene expression and
POMC-derived peptides levels (Kitamura et al., 2006; Plum
et al., 2009), the increased FoxO1 nuclear retention in POMC
neurons with concurrent unaltered hypothalamic Pomc geneexpression and POMC-derived peptides levels in mutant mice
(Figures 3 and 7D) may seem to be at odds with those previous
results. However, one explanation for this conundrum may be
that lack of SIRT1 leads to FoxO1 hyperacetylation and hence
inhibition. Future studies will be required to determine the intra-
cellular consequences of SIRT1 deletion in POMC neurons on
the acetylation statuses of FoxO1 and other SIRT10s targets.
As mentioned above, another interesting aspect unveiled by
our study is the very selective and physiologically relevant
connection between POMC neurons and perigonadal WAT.
The rationale for this network may rest on the fact that this
circuitry is in place to allow the mammalian body to finely tune
its energy expenditure following changes in food availability.
This idea is in line with other CNS-mediated selective regulations
of homeostatic pathways. For example, baroreflex activation
triggers SNA subserving cardiovascular system, but not inter-
scapular BAT (Rahmouni and Haynes, 2004). Also, neurons in
the hypothalamic median preoptic area selectively increase
SNA in interscapular BAT to elevate body temperature after
immune challenges (Lazarus et al., 2007). Moreover, neurons
within the ventromedial hypothalamic nucleus convey hormonal
signals into enhanced SNA in skeletal muscle to increase
glucose uptake at times it is most needed (e.g., during wakeful-
ness) (Minokoshi et al., 1999; Toda et al., 2009). Furthermore,
leptin-receptor-expressing hypothalamic neurons have been
reported to regulate SNA in a fat-selective fashion (Plum et al.,
2007). Collectively, our and previously reported results strongly
indicate that specific branches of the sympathetic nervous
system are activated by specific stimuli to allow only selective
responses (i.e., the ones required to cope with that particular
stimulus) to be triggered.
Along these lines, enhanced BAT function has been sug-
gested as an alternative antiobesity strategy (Kajimura et al.,
2009; Seale et al., 2009). This concept has been recently galva-
nized due to the fact that BAT, a tissue previously thought to be
present only in infants, is functionally active in adult humans as
well (Cypess et al., 2009). Yet available means to activate/
expand BAT in humans are limited, as they may include chronic
administrations of adrenergic receptors’ agonists that, unfortu-
nately, have well-characterized deleterious actions. Here we
report that SIRT1 in POMC neurons selectively coordinates
BAT in perigonadal WAT via the sympathetic nervous system.
There are several neuronal networks by which POMC neurons
can regulate SNA in this fat depot: one may involve a direct
control of sympathetic preganglionic neurons in the spinal
cord as POMC neurons project to these sites (Elias et al.,
1998); another possibility is via POMC-neuron-mediated control
of neurons within paraventricular hypothalamic nucleus (a well-
known site for autonomic regulation). Regardless to the circuitry,
the specificity of POMC-neurons-to-perigonadal WAT control
indicate that this network may represent a novel route to finely
tune SNA and BAT function in a tissue-selective fashion, hence
avoiding deleterious effects of systemic and tissue-unspecific
adrenergic receptors stimulation. Human clinical trials to test
the antidiabetic efficacy of putative SIRT1 activators are
currently underway (Elliott and Jirousek, 2008). We suggest
that pharmacological manipulations of SIRT1 in CNS neurons
should also be contemplated for the treatment of diet-induced
obesity.Cell Metabolism 12, 78–87, July 7, 2010 ª2010 Elsevier Inc. 85
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Metabolic Actions of SIRT1 in POMC NeuronsEXPERIMENTAL PROCEDURES
Generation of Pomc-Cre; Sirt1loxP/loxP Mice
Mice were housed in groups of four to five with food (either a SC rodent diet
or the HC diet D12331 from Research Diets, New Brunswick, NJ) and water
available ad libitum in light- and temperature-controlled environments unless
otherwise specified. Care of mice was within the Institutional Animal Care
and Use Committee (IACUC) guidelines, and all the procedures were approved
by the University of Texas Southwestern Medical Center IACUC. Pomc-Cre
mice (Balthasar et al., 2004) were mated with mice carrying a loxP-flanked
Sirt1 allele (Sirt1loxP) (Cheng et al., 2003). Breeding colonies were maintained
by mating Pomc-Cre; Sirt1loxP/loxP and Sirt1loxP/loxP mice. Only animals on
same mixed background strain generation were compared to each other.
Tail DNA was collected from each animal to determine the presence of the
Pomc-Cre transgene, the loxP-flanked, and/or the Cre-deleted Sirt1 allele
by PCR analyses as previously described (Balthasar et al., 2004; Cheng
et al., 2003). The Pomc-Cre transgene is sporadically turned on during game-
togenesis, before the first meiotic division (Balthasar et al., 2004). Thus, all
mice positive for the Cre-deleted Sirt1 allele in tail DNA samples were excluded
from our studies. Tissues PCR genotyping analyses for determining the pres-
ence of the loxP-flanked and/or the Cre-deleted Sirt1 allele were done as
previously described (Cheng et al., 2003). Sterile saline solution (placebo) or
the selective b3-adrenergic receptor agonist CL316,243 at 1 mg kg1, was
injected intraperitoneally (i.p.) into age-matched, 7- to 8-month-old, HC-fed
females daily for 7 days.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2010.05.010.
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